Literature DB >> 30275176

Spinal Ewing Sarcoma Debuting with Cord Compression: Have We Discovered the Thread of Ariadne?

Stergios Boussios1, Catherine Hayward2, Deirdre Cooke2, Nikolaos Zakynthinakis-Kyriakou3, Alexandros K Tsiouris4, Aikaterini A Chatziantoniou5, Foivos S Kanellos4, Afroditi Karathanasi2.   

Abstract

Ewing's sarcoma (ES) of the spine with cord or radicular compression as an initial sign is infrequent. It is unclear, in alleviating a neurological deficit, whether decompressive laminectomy is preferred over chemotherapy. Herein, a literature review of the treatment approaches to the primary or metastatic ES of the spine has been performed. Collected data included clinical features of the patients, treatment, and outcome. There are reported 69 cases with initial presentation of cord or radicular compression of spinal cord, arising from primary or metastatic ES, treated either with initial chemotherapy and/or radiotherapy (RT) (33.33%, n=23), or decompressive surgery (66.66%, n=46). The median age at diagnosis was 17.95 years old (range=0.06-60), and 38 patients (55.07%) were male. Eighteen (78.26%) were initially treated with chemotherapy combined with RT, whereas 3 (13.04%) were managed with RT alone. One patient (4.35%) received only corticosteroids, while there are not available data for the treatment of another one (4.35%). The remaining 46 patients (66.66%) were initially treated with decompressive surgery. Among them, 40 (57.97%) received postoperative chemotherapy, RT or combined modality therapy, whereas 6 patients (8.69%) were not treated adjuvantly. Sixteen out of 23 patients (69.6%) treated with systemic therapy, and 37 from 46 (80.43%) of those managed with decompressive laminectomy were still alive at a mean follow-up period of 2.11 years (range=0.16-6) and 3.45 years (range=0.16-26.08), respectively. To summarize, spinal resection and reconstruction followed by adjuvant treatment reduce the risk of local recurrence, and improve long-term survival. However, ES of the spine is not a distinct clinical entity and can be either managed with chemotherapy and/or RT, similarly to other localization. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Ewing's sarcoma; chemotherapy; decompressive surgery; radiotherapy; review; spinal cord compression

Mesh:

Year:  2018        PMID: 30275176     DOI: 10.21873/anticanres.12893

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Separation Surgery in the Treatment of Spinal Metastasis.

Authors:  Rui-Feng Li; Rui-Qi Qiao; Ming-You Xu; Rong-Xing Ma; Yong-Cheng Hu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  Prognostic Significance of Preoperative Inflammatory Biomarkers and Traditional Clinical Parameters in Patients with Spinal Metastasis from Clear Cell Renal Cell Carcinoma: A Retrospective Study of 95 Patients in a Single Center.

Authors:  Kehan Xu; Jialin Li; Mengzi Hu; Hao Zhang; Jian Yang; Haiyi Gong; Bo Li; Wei Wan; Jianru Xiao
Journal:  Cancer Manag Res       Date:  2020-01-07       Impact factor: 3.989

3.  Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK.

Authors:  Sidrah Shah; Mikolaj Kutka; Kathryn Lees; Charlotte Abson; Maher Hadaki; Deirdre Cooke; Cherie Neill; Matin Sheriff; Afroditi Karathanasi; Stergios Boussios
Journal:  J Pers Med       Date:  2021-02-09

Review 4.  State-of-the-Art Imaging Techniques in Metastatic Spinal Cord Compression.

Authors:  Tricia Kuah; Balamurugan A Vellayappan; Andrew Makmur; Shalini Nair; Junda Song; Jiong Hao Tan; Naresh Kumar; Swee Tian Quek; James Thomas Patrick Decourcy Hallinan
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.